Ray Dalio Heska Corp Transaction History

Bridgewater Associates, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$62.17 - $97.62 $28,473 - $44,709	458 Added 3.79%	12,534 $1.22 Million
Q4 2022 Feb 13, 2023	SELL	$60.21 - $77.74 $248,185 - $320,444	-4,122 Reduced 25.45%	12,076 $750,000
Q3 2022 Nov 10, 2022	BUY	$72.92 - $99.73 $656 - $897	9 Added 0.06%	16,198 $1.18 Million
Q2 2022 Aug 11, 2022	BUY	$84.23 - $147.57 $124,828 - $218,698	1,482 Added 10.08%	16,189 $1.53 Million
Q1 2022 May 13, 2022	BUY	$122.89 - $171.74 $423,847 - $592,331	3,449 Added 30.64%	14,707 $2.03 Million
Q4 2021 Feb 14, 2022	BUY	$156.0 - $265.78 $197,184 - $335,945	1,264 Added 12.65%	11,258 $2.05 Million
Q3 2021 Nov 12, 2021	SELL	$228.69 - $274.2 $169,916 - $203,730	-743 Reduced 6.92%	9,994 $2.58 Million
Q2 2021 Aug 13, 2021	BUY	$169.89 - $231.37 $1.82 Million - $2.48 Million	10,737 New	10,737 $2.47 Million

26K

Ticker HSKA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 10,818,900
Description
Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.